We have 3 of 33 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Molecular design and delivery of extracellular and membrane protein degradation chimeras.
This Review provides a framework for selecting disease-matched degradation routes and advancing meTPDs from platform-specific demonstrations towards predictable therapeutic modalities by integrating molecular design, receptor biology, intracellular trafficking, delivery and pharmacodynamic considerations.
Molecular Engineering of Stimuli-Activatable Protein Degraders for Precise Cancer Therapy.
This Account systematically summarizes recent advances regarding the rational design of stimuli-activatable protein degraders, and strategically outline the "when and how" of integrating these degraders with nanomedicine platforms to tailor precise cancer therapy.